mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |